Skip to main content
Equibles

PRUDENTIAL FINANCIAL INC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1137774 NEWARK, NJ
Back to TGTX Full portfolio

Position in TGTX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$9,252,994
+$3,788,304 QoQ
Shares Held
168,420
+2.4% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#72
of 426 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRUDENTIAL FINANCIAL INC holds $557,787,882 across 190 Biotechnology names. TGTX ranks #16 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 130,659 $81,471,112
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 133,294 $66,211,127
3 BMRN
Biomarin Pharmaceutical Inc
 392,811 $22,476,644
4 INCY
Incyte Corp
 191,312 $21,687,128
5 CYTK
Cytokinetics Inc
 214,535 $18,276,236
6 LGND
Ligand Pharmaceuticals Inc
 54,623 $17,265,784
7 PTCT
Ptc Therapeutics, Inc.
 185,820 $15,157,337
8 MRVI
Maravai Lifesciences Holdings, Inc.
 2,152,154 $13,429,440

All Filings in TGTX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,252,994 168,420
2026-03-31 $5,464,690 164,500
2025-12-31 $5,533,034 185,610
2025-09-30 $7,057,379 195,360
2025-06-30 $6,813,446 189,315
2025-03-31 $7,073,347 179,390
2024-12-31 $5,074,107 168,575
2024-09-30 $7,141,831 305,337
2024-06-30 $1,522,628 85,589
2024-03-31 $160,525 10,554
2023-12-31 $180,279 10,555
2023-09-30 $85,480 10,225
2023-06-30 $1,372,583 55,257
2023-03-31 $2,159,668 143,595
2021-12-31 $178,429 9,391
2021-09-30 $349,173 10,492
2021-06-30 $433,866 11,185
2021-03-31 $524,175 10,875
2020-12-31 $536,274 10,309
2020-09-30 $258,180 9,648